FAQ

Perspirex works so effectively thanks to the active ingredient Aluminium Chloride Hexahydrate. The Aluminium Chloride Hexahydrate reacts with water and keratin in the sweat duct by temporarily forming a gel-plug preventing the sweat from reaching the surface of the skin. The active skin care system reduces or even minimises the skin irritation commonly known from “highly effective” antiperspirants.

The gel plug is dispelled over the course of a few days with the natural shedding of dead skin cells which is why you only have to reapply Perspirex 2-3 times a week.

Perspirex contains alcohol due to the following advantages:

• Cleans and disinfects the skin
• Reduces odour development
• Since alcohol is also a disinfectant, there is no need to add preservatives to Perspirex
• Alcohol quickly evaporates from the skin leaving the skin dry
• Degreases the skin so that the formulation works uniformly on the skin

The active ingredient in all Perspirex products is aluminium chloride. Aluminium chloride is used as it is extremely efficient in forming a long-lasting gel-plug in sweat ducts. Its effect has been well documented in both literature and in clinical tests. Aluminium chloride can irritate the skin and therefore the active skin care system has been added to the formulation. The skin care technology reduces skin irritation which makes the roll-on formulations quite unique.

The sweat glands are less active at night. Consequently, the water level in the sweat glands is low and the gel-plug forms more effectively in the sweat duct. This provides you with long-lasting protection against sweat and odour.

Apply Perspirex on dry and unbroken skin in a small amount – only 2 strokes up and 2 strokes down – as a thin film, evenly distributed in the centre of the armpit area where you have hair growth. This is sufficient to provide effective sweat and odour protection that lasts for 3-5 days.

In some cases Perspirex may cause skin irritation. If you experience this, we recommend to discontinue use.

Most of the skin irritations are temporary and occur after the first or second application, but if consistent skin irritations or an allergic reaction occur, the use should be discontinued.

Yes, you can continue to apply your regular scented deodorant or perfume should you wish. This will not affect the efficacy of Perspirex.

Yes, Perspirex is safe to use, also during pregnancy and breast feeding.

Cosmetic products are subject to the European Cosmetics Regulation (1223/2009). This legislation requires a cosmetic product not to cause harm to human health under normal conditions of use. Each cosmetic product must undergo a safety assessment by a duly qualified safety assessor before being placed on the market. This assessment takes account of each of the ingredients and the intended use of the product. Only if the cosmetic products are concluded to be safe for human use, according to the requirements of the European Cosmetic Regulation (1223/2009), will the product be placed on the European market.

Consequently, Perspirex is produced according to prevailing cosmetic legislation, in all our markets. If you are in doubt regarding the ingredients of Perspirex in relation to pregnancy or breastfeeding, please consult your doctor for advice.

No, there is no evidence that aluminium in antiperspirants could increase the risk of breast cancer.

This was confirmed by a review of all of the available evidence in 2014 that found no link between the use of antiperspirants and breast cancer (ref. Cancer Research UK; www.cancerresearchuk.org). Also, according to the American Cancer Society, no epidemiologic studies exist, which report a statistical association between breast cancer risk and the use of antiperspirants.

To the contrary, a carefully designed epidemiologic study of this issue published in 2002 compared 813 women with breast cancer and 793 women without the disease and found no relationship between breast cancer risk and antiperspirant use, deodorant use, or underarm shaving.

No. Although initial studies linked aluminium toxicity with Alzheimer’s disease, the link has not been proven despite continuing investigation over the past 40 years. The US Alzheimer’s Association maintains that there is no evidence to suggest that aluminium exposure increases the risk of developing Alzheimer’s disease.

The research community is generally convinced that aluminium is not a key risk factor in developing Alzheimer’s disease. Public health bodies sharing this conviction include the World Health Organization (WHO), the U.S. National Institutes of Health, the U.S. Environmental Protection Agency, and Health Canada.